Clinical Trial: Observational Study on Endometrial Stromal Tumors
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Endometrial Stromal Tumors: an Observational Study
Brief Summary: Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)
Detailed Summary:
Observational, retrospective and prospective study on EST aimed to understand more about its biology, natural history and antitumor activity of different treatment options.
This study will collect data in prospective and retrospective way of patients affected by EST and treated according disease guidelines and local practices.
The study will also review the diagnosis by a central expert pathologist in order to its confirmation
Sponsor: Italian Sarcoma Group
Current Primary Outcome: Disease natural history [ Time Frame: Through survival, an average of 5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Disease diagnosis and classification [ Time Frame: At the time of diagnosis, an average of 1 month ]Highlight some main issues in pathologic diagnosis of these tumors and their classification
- Chemotherapy received treatment [ Time Frame: Through treatment completion, an average of 24 month ]Number and type of chemotherapy agents received for EST treatment
Original Secondary Outcome: Same as current
Information By: Italian Sarcoma Group
Dates:
Date Received: July 8, 2016
Date Started: October 2016
Date Completion: August 2022
Last Updated: January 9, 2017
Last Verified: January 2017